Mostafa et al. [15] reported that estradiol-ERα signaling plays a negative role in IFNγ inducible MHC II expression via reducing expression of class II transactivator (CIITA), which increases expression of MHC I and II, in breast cancer cells. Here, IFNG is linked to breast carcinoma.